Citius Oncology (CTOR) Other Non-Current Assets (2023 - 2026)

Citius Oncology's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $169252.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 99.77% year-over-year to $169252.0; the TTM figure through Mar 2026 stood at $169252.0 (down 99.77% YoY), while the FY2025 annual figure was $73.4 million, changed 0.0% from the prior year.
• Other Non-Current Assets was $169252.0 for Q1 2026 at Citius Oncology, down from $72.8 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $73.4 million in Q3 2024 to a low of $169252.0 in Q1 2026.
• Historically, Other Non-Current Assets has averaged $60.0 million across 4 years, with a median of $73.4 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Other Non-Current Assets surged 83.5% in 2024, then plunged 99.77% in 2026.
• A 4-year view of Other Non-Current Assets shows it stood at $40.0 million in 2023, then soared by 83.5% to $73.4 million in 2024, then dropped by 0.78% to $72.8 million in 2025, then slumped by 99.77% to $169252.0 in 2026.
• The last three Other Non-Current Assets figures came in at $169252.0 (Q1 2026), $72.8 million (Q4 2025), and $73.4 million (Q3 2025), per Business Quant data.